| Followers | 608 |
| Posts | 42247 |
| Boards Moderated | 6 |
| Alias Born | 01/10/2004 |
Thursday, May 20, 2010 7:39:34 AM
Thursday, May 20, 2010 6:40 AM
Scottrade.com
This email is compliments of Scottrade.com
News for 'PDMI' - (ARVO Meeting Yields Positive Results for Paradigm)
SALT LAKE CITY, UT, May 20, 2010 (MARKETWIRE via COMTEX) -- Paradigm Medical
Industries, Inc. (PINKSHEETS: PDMI) announced today that attendance at the
recent Association for Research in Vision and Ophthalmology (ARVO) meeting, held
in Ft. Lauderdale, Florida from May 2-5, 2010 exceeded expectations. "The ARVO
meeting was an excellent opportunity for Paradigm to continue to develop
cooperative professional relationships and introduce the Paramax, a new device
currently under FDA review pursuant to a 510(k) application. The meeting also
resulted in several new product development opportunities," said Stephen Davis,
the Company's President and CEO.
The ARVO Meeting was attended by Mr. Davis and Julio Maximo, the Company's Vice
President of Operations. Although the meeting format is not generally considered
a "selling" meeting, Paradigm actually sold over $125,000 of its equipment. The
Company also received many leads that might result in future sales of its
equipment.
During the time spent in Ft. Lauderdale, Mr. Davis met with new product
developers, development engineers, financial partners and many physicians who
represent leadership roles in the ophthalmic industry. "I am pleased with the
results of the time spent with companies and individuals at the meeting, but I
am more pleased with the renewed interest in our current and new products. This
meeting will definitely help put Paradigm Medical back on the map," added Mr.
Davis.
About Paradigm Medical Industries, Inc.
Paradigm Medical Industries, Inc. is a medical device company that develops,
manufactures and distributes ophthalmic diagnostic instruments and related
products for early detection of glaucoma and other eye disorders. The Company's
primary objective is to capture a niche market within the glaucoma and
ultrasound microscopy fields. The Company markets its products to
ophthalmologists, optometrists, universities, and clinics throughout the United
States and internationally.
This press release contains statements that, if not verifiable historic fact,
may be viewed as forward-looking statements that could predict future events and
outcomes with respect to Paradigm and its business. The predictions embodied in
these statements will involve risk and uncertainties and, accordingly, actual
results may differ significantly from the results discussed or implied in such
forward-looking statements.
Contact:
Stephen L. Davis
President and Chief Executive Officer
801-977-8970
www.paradigm-medical.com
SOURCE: Paradigm Medical Industries, Inc.
CONTACT: http://www.paradigm-medical.com
Copyright 2010 Marketwire, Inc., All rights reserved.
-0-
SUBJECT CODE: Medical and Healthcare:Dentistry
Medical and Healthcare:Facilities and Providers
Medical and Healthcare:Health and Nutrition
Medical and Healthcare:Healthcare
Pharmaceuticals and Biotech:Equipment and Supplies
Medical and Healthcare:Mental Health
Medical and Healthcare:Nursing
Medical and Healthcare:Surgery and Treatments
Medical and Healthcare:Medical Devices
Medical and Healthcare:Alternative
Source: Comtex Wall Street News
Stop By And Visit Me At The SmallCap Trading Techniques Board
http://investorshub.advfn.com/boards/board.aspx?board_id=4203
Valuable Trading Ideas to help you make more MOMO!
http://investorshub.advfn.com/boards/board.aspx?board_id=4203
Isiah Enterprises Activates Scalable Materials Platform Targeting $900B+ Global Market Opportunity; Initiates Strategic Partner Alignment Phase • OWPC • Mar 25, 2026 9:07 AM
ECGI Signs Definitive $25 Million Agreement to Acquire RezyFi • ECGI • Mar 24, 2026 8:30 AM
Cannabix Technologies Announces First Delivery of Marijuana Breath Test (MBT) to a Major Construction Client • BLOZF • Mar 19, 2026 12:45 PM
ECGI Building in Crypto's Top-Performing Sector as Tokenized Real-World Assets Surge Past $26 Billion • ECGI • Mar 19, 2026 8:30 AM
Advances in Domestic Heavy Rare Earth Minerals Production Essential for North American Defense Stockpiles • ALOY • Mar 18, 2026 9:00 AM
ECGI Advances $10M Mortgage Tokenization Pilot as SEC Interpretation Adds Clarity • ECGI • Mar 18, 2026 8:45 AM
